You just read:

Watson Announces Approval of Nulecit™, the First Generic Alternative to Ferrlecit® for the Treatment of Iron Deficiency Anemia

News provided by

Watson Pharmaceuticals, Inc.

Mar 31, 2011, 01:56 ET